|
SPG20 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77260000011614E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.20379994861253E-09 |
| Normal-vs-Stage2 |
1.788460E-04 |
| Normal-vs-Stage3 |
3.221600E-03 |
| Normal-vs-Stage4 |
1.341390E-01 |
| Stage1-vs-Stage2 |
2.515000E-01 |
| Stage1-vs-Stage3 |
5.412300E-02 |
| Stage1-vs-Stage4 |
9.722300E-02 |
| Stage2-vs-Stage3 |
6.435200E-01 |
| Stage2-vs-Stage4 |
4.962400E-01 |
| Stage3-vs-Stage4 |
7.671800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.69879999459377E-08 |
| Normal-vs-AfricanAmerican |
1.98979999999072E-06 |
| Normal-vs-Asian |
1.063380E-01 |
| Caucasian-vs-AfricanAmerican |
9.068000E-01 |
| Caucasian-vs-Asian |
8.414800E-01 |
| AfricanAmerican-vs-Asian |
8.261800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.90780002696079E-09 |
| Normal-vs-Female |
1.9085099999927E-05 |
| Male-vs-Female |
1.827820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.94350000004562E-06 |
| Normal-vs-Extreme_Weight |
3.5156988431595E-11 |
| Normal-vs-Obese |
2.14119999999429E-05 |
| Normal-vs-Extreme_Obese |
1.560980E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.033400E-01 |
| Normal_Weight-vs-Obese |
4.615400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.940800E-01 |
| Extreme_Weight-vs-Obese |
2.768400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.641000E-01 |
| Obese-vs-Extreme_Obese |
8.547400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.80809999997356E-06 |
| Normal-vs-Age(41-60Yrs) |
3.5511999996185E-07 |
| Normal-vs-Age(61-80Yrs) |
4.45540004889722E-09 |
| Normal-vs-Age(81-100Yrs) |
1.368940E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.469200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.447800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.995800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.237600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.513000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.401800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.63389310362072E-12 |
| Normal-VS-Type2 PRCC |
4.601500E-03 |
| Normal-VS-KIRP CIMP |
1.80080000000693E-06 |
| Normal-VS-Unclassified PRCC |
1.84605999999921E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.432700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.945400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.800400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.877900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.277420E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.349700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.34219999999397E-05 |
| Normal-vs-N1 |
6.968400E-02 |
| Normal-vs-N2 |
4.657200E-01 |
| N0-vs-N1 |
2.044800E-01 |
| N0-vs-N2 |
7.376800E-01 |
| N1-vs-N2 |
8.146800E-01 |
|
|
